ATUM

IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

New York, United States & Pune, Maharashtra, India:  October 23, 2020 Partners aim to provide potent neutralizing antibodies for COVID-19…

Read More »